MJBizDaily
Why cannabis banking reform alone won’t solve payment processing woes
Latest Posts
Illinois Dispensaries Rack Up $801K in Sales
Dispensaries in Illinois recorded $801,000 in medical cannabis sales since the program launched in early November, according to the first official figures released by the state. Illinois now has 16…
News December 10
California marijuana leaders increasingly uniting behind one legalization measure
Late last month, it looked as though California might very well have two recreational cannabis legalization measures on the ballot next fall. But the situation is changing rapidly, and the odds…
News December 10Study: Marijuana Motivates Almost Half of Colorado Tourists
It must be the marijuana. A state tourism survey released Wednesday found that Colorado’s legalized marijuana influenced nearly half of the visitors who decide to come visit the state. The…
News December 10Maryland MMJ Industry Fires Up Real Estate Market
Marijuana entrepreneurs seeking cultivation licenses in Maryland have given the state’s industrial real estate market a lift over the past year. Many applicants have already secured warehouses for grow sites…
News December 9Last Chance to Take Cannabis Banking Survey
Marijuana Business Daily is conducting a brief online survey of cannabis professionals to get a pulse on the state of banking services for companies in the industry. The survey, which…
News December 9Merrill Lynch Report Rosy on Cannabis Companies
Merrill Lynch is bullish on the medical marijuana business. In a 45-page report that explores the marijuana-related investment landscape, the investment management arm of Bank of America concludes that “medical…
News December 9
Cannabis industry, advocates trying to find right balance on marijuana legalization
By John Schroyer Business and advocates both play a key role in furthering marijuana legalization, but finding the ideal balance is proving difficult. That was particularly evident with Ohio’s ill-fated legalization measure,…
News December 9GW Pharma Boosts Production in Expectation of FDA Approval
GW Pharmaceuticals is reportedly increasing its manufacturing capacity for medical marijuana and a specific cannabis-based drug it has developed for epileptics called Epidiolex. The British company is boosting production in…
News December 9Early sales in NY could benefit CT grower
Under an “emergency” bill signed last month by New York Gov. Andrew Cuomo, qualified medical cannabis patients are supposed to receive expedited access to MMJ. But that hasn’t come to…
News December 8
Latest Sponsored
